According to the results of the rating "Ukrainian People's Award", the drug "Atoxil" was recognized as the leader in the nomination "Best Sorbent of 2014".

The Ukrainian People's Award is the first and only all-Ukrainian national project, the main goal of which is to optimize the national market of goods and services by identifying its best representatives based on a popular vote.

Therapeutic efficacy of the drug Atoxil:

  • elimination of manifestations of intoxication and poisoning (nausea, vomiting, weakness, indigestion);
  • elimination of stomach and intestinal disorders (diarrhea, bloating, dysbiosis);
  • reduction of toxic-allergic reactions, elimination of skin manifestations of allergies, itching;
  • elimination of intoxication syndrome in liver and kidney diseases.

Recommendations for use:

  • acute intestinal infections,
  • food poisoning,
  • diarrhea,
  • dysbacteriosis,
  • food allergic diseases (atopic dermatitis, urticaria, diathesis),
  • dermatological diseases (psoriasis, eczema, dermatitis),
  • liver diseases (acute and chronic),
  • chronic renal failure, pyelonephritis.

Atoxil – a drug with a high safety profile, it is not broken down and is not absorbed in the gastrointestinal tract. Therefore, it is recommended for almost all groups of patients, from the first year of life.

Atoxil registered as a medicinal product that has passed all stages of clinical trials and confirmed its high effectiveness and safety in use.

Silicon dioxide, which is part of the drug Atoxil, manufactured by Orisil-Pharm, has been tested for compliance with FDA and USA Pharmacopoeia standards according to USP 29-NF24 monographic tests.